Alterations In Creatine Kinase, Phosphate And Lipid Values In Patients With Chronic Myeloid Leukemia During Treatment With Imatinib
HAEMATOLOGICA(2008)
摘要
Imatinib, the treatment of choice for chronic myeloid leukemia, is generally well tolerated. We present here data from a retrospective analysis on metabolic abnormalities occurring during therapy which show increased creatine kinase, inverse creatine kinase-phosphate correlation, cholesterol and triglyceride values.
更多查看译文
关键词
CML, tyrosine kinase inhibitor, long term side effects, CK
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要